Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000930413-09-001133
Filing Date
2009-03-02
Accepted
2009-03-02 17:01:55
Documents
14
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 c56743_10k.htm 10-K 1561221
2 GRAPHIC c56743graphfinal.jpg GRAPHIC 23645
3 c56743_ex10-29.htm EX-10.29 22220
4 c56743_ex10-30.htm EX-10.30 22285
5 c56743_ex10-31.htm EX-10.31 22234
6 c56743_ex10-32.htm EX-10.32 22386
7 c56743_ex10-33.htm EX-10.33 22069
8 c56743_ex10-34.htm EX-10.34 22174
9 c56743_ex21-1.htm EX-21.1 1909
10 c56743_ex23-1.htm EX-23.1 1676
11 c56743_ex31-1.htm EX-31.1 11245
12 c56743_ex31-2.htm EX-31.2 11298
13 c56743_32-1.htm EX-32.1 3741
14 c56743_32-2.htm EX-32.2 4020
  Complete submission text file 0000930413-09-001133.txt   1762721
Mailing Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816
Business Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816 7324189300
SAVIENT PHARMACEUTICALS INC (Filer) CIK: 0000722104 (see all company filings)

EIN.: 133033811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15313 | Film No.: 09648384
SIC: 2833 Medicinal Chemicals & Botanical Products